{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:29:46Z","timestamp":1783024186866,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fund for Scientific Research Flanders","award":["FR-1106521N"],"award-info":[{"award-number":["FR-1106521N"]}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["CHDI Foundation"],"award-info":[{"award-number":["CHDI Foundation"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00259-025-07394-w","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:45:46Z","timestamp":1750200346000},"page":"5124-5134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["PET imaging with [\u00b9\u00b9C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington\u2019s disease"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8497-2314","authenticated-orcid":false,"given":"Aline","family":"Delva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Serdons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Skinbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Khetarpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Bard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Doot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"7394_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ. Huntington\u2019s disease: a clinical review. Eur J Neurol. 2018;25:24\u201334. https:\/\/doi.org\/10.1111\/ene.13413.","journal-title":"Eur J Neurol"},{"key":"7394_CR2","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/mds.29228","volume":"37","author":"A Medina","year":"2022","unstructured":"Medina A, Mahjoub Y, Shaver L, Pringsheim T. Prevalence and incidence of Huntington\u2019s disease: an updated systematic review and meta-analysis. Mov Disord. 2022;37:2327\u201335. https:\/\/doi.org\/10.1002\/mds.29228.","journal-title":"Mov Disord"},{"key":"7394_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC, Flower MD, Scahill RI, Wild EJ, et al. Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol. 2022;21:645\u201358. https:\/\/doi.org\/10.1016\/S1474-4422(22)00121-1.","journal-title":"Lancet Neurol"},{"key":"7394_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28855","volume":"37","author":"JJ Ferreira","year":"2022","unstructured":"Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, et al. An MDS evidence-based review on treatments for Huntington\u2019s disease. Mov Disord. 2022;37:25\u201335. https:\/\/doi.org\/10.1002\/mds.28855.","journal-title":"Mov Disord"},{"key":"7394_CR5","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI80743","volume":"125","author":"EJ Wild","year":"2015","unstructured":"Wild EJ, Boggio R, Langbehn D, Robertson N, Haider S, Miller JR, et al. Quantification of mutant Huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients. J Clin Invest. 2015;125:1979\u201386. https:\/\/doi.org\/10.1172\/JCI80743.","journal-title":"J Clin Invest"},{"key":"7394_CR6","doi-asserted-by":"publisher","first-page":"12003","DOI":"10.1021\/acs.jmedchem.1c00667","volume":"64","author":"L Liu","year":"2021","unstructured":"Liu L, Johnson PD, Prime ME, Khetarpal V, Lee MR, Brown CJ, et al. [(11)C]CHDI-626, a PET tracer candidate for imaging mutant Huntingtin aggregates with reduced binding to AD pathological proteins. J Med Chem. 2021;64:12003\u201321. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00667.","journal-title":"J Med Chem"},{"key":"7394_CR7","doi-asserted-by":"publisher","unstructured":"Bertoglio D, Bard J, Hessmann M, Liu L, G\u00e4rtner A, De Lombaerde S, et al. Development of a ligand for in vivo imaging mutant huntingtin in Huntington\u2019s disease. Sci Transl Med. 2022;14(630):eabm3682. https:\/\/doi.org\/10.1126\/scitranslmed.abm3682.","DOI":"10.1126\/scitranslmed.abm3682"},{"key":"7394_CR8","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1021\/acs.jmedchem.0c00955","volume":"63","author":"L Liu","year":"2020","unstructured":"Liu L, Prime ME, Lee MR, Khetarpal V, Brown CJ, Johnson PD, et al. Imaging mutant Huntingtin aggregates: development of a potential PET ligand. J Med Chem. 2020;63:8608\u201333. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00955.","journal-title":"J Med Chem"},{"key":"7394_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05578-8","author":"D Bertoglio","year":"2021","unstructured":"Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Mrzljak L, et al. Longitudinal preclinical evaluation of the novel radioligand [11\u00a0C]CHDI-626 for PET imaging of mutant Huntingtin aggregates in Huntington\u2019s disease. Eur J Nucl Med Mol Imaging. 2021. https:\/\/doi.org\/10.1007\/s00259-021-05578-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7394_CR10","doi-asserted-by":"publisher","first-page":"17977","DOI":"10.1038\/s41598-021-97334-z","volume":"11","author":"F Herrmann","year":"2021","unstructured":"Herrmann F, Hessmann M, Schaertl S, Berg-Rosseburg K, Brown CJ, Bursow G, et al. Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates. Sci Rep. 2021;11:17977. https:\/\/doi.org\/10.1038\/s41598-021-97334-z.","journal-title":"Sci Rep"},{"key":"7394_CR11","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2967\/jnumed.123.265569","volume":"64","author":"D Bertoglio","year":"2023","unstructured":"Bertoglio D, Weiss AR, Liguore W, Martin LD, Hobbs T, Templon J, et al. In vivo cerebral imaging of mutant Huntingtin aggregates using (11)C-CHDI-180R PET in a nonhuman primate model of Huntington disease. J Nucl Med. 2023;64:1581\u20137. https:\/\/doi.org\/10.2967\/jnumed.123.265569.","journal-title":"J Nucl Med"},{"key":"7394_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00259-022-05945-z","volume":"50","author":"A Delva","year":"2022","unstructured":"Delva A, Koole M, Serdons K, Bormans G, Liu L, Bard J, et al. Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [(11)C]CHDI-00485180-R and [(11)C]CHDI-00485626, designed for quantification of cerebral aggregated mutant Huntingtin. Eur J Nucl Med Mol Imaging. 2022;50:48\u201360. https:\/\/doi.org\/10.1007\/s00259-022-05945-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7394_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19:224\u201347. https:\/\/doi.org\/10.1002\/hbm.10123.","journal-title":"Hum Brain Mapp"},{"key":"7394_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11\u00a0C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740\u20137. https:\/\/doi.org\/10.1038\/jcbfm.1990.127.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7394_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00259-011-1745-9","volume":"38","author":"BA Thomas","year":"2011","unstructured":"Thomas BA, Erlandsson K, Modat M, Thurfjell L, Vandenberghe R, Ourselin S, et al. The importance of appropriate partial volume correction for PET quantification in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2011;38:1104\u201319. https:\/\/doi.org\/10.1007\/s00259-011-1745-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7394_CR16","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, et al. Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology. J Neurosci. 1999;19:2522\u201334. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-07-02522.1999.","journal-title":"J Neurosci"},{"key":"7394_CR17","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1073\/pnas.0437660100","volume":"100","author":"S Iuchi","year":"2003","unstructured":"Iuchi S, Hoffner G, Verbeke P, Djian P, Green H. Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine. Proc Natl Acad Sci U S A. 2003;100:2409\u201314. https:\/\/doi.org\/10.1073\/pnas.0437660100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7394_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.nucmedbio.2007.06.003","volume":"34","author":"J Logan","year":"2007","unstructured":"Logan J, Alexoff D, Kriplani A. Simplifications in analyzing positron emission tomography data: effects on outcome measures. Nucl Med Biol. 2007;34:743\u201356. https:\/\/doi.org\/10.1016\/j.nucmedbio.2007.06.003.","journal-title":"Nucl Med Biol"},{"key":"7394_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JHD-210475","volume":"11","author":"JH Warner","year":"2022","unstructured":"Warner JH, Long JD, Mills JA, Langbehn DR, Ware J, Mohan A, et al. Standardizing the CAP score in Huntington\u2019s disease by predicting age-at-onset. J Huntingtons Dis. 2022;11:153\u201371. https:\/\/doi.org\/10.3233\/JHD-210475.","journal-title":"J Huntingtons Dis"},{"key":"7394_CR20","doi-asserted-by":"publisher","unstructured":"Uzuegbunam BC, Librizzi D, Hooshyar Yousefi B. PET Radiopharmaceuticals for Alzheimer\u2019s disease and Parkinson\u2019s disease diagnosis, the current and future landscape. Molecules. 2020;25. https:\/\/doi.org\/10.3390\/molecules25040977.","DOI":"10.3390\/molecules25040977"},{"key":"7394_CR21","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2967\/jnumed.121.263195","volume":"63","author":"M Chapleau","year":"2022","unstructured":"Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici GD. The role of amyloid PET in imaging neurodegenerative disorders: a review. J Nucl Med. 2022;63:S13\u20139. https:\/\/doi.org\/10.2967\/jnumed.121.263195.","journal-title":"J Nucl Med"},{"key":"7394_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1212\/WNL.0b013e318245d295","volume":"78","author":"KM Rodrigue","year":"2012","unstructured":"Rodrigue KM, Kennedy KM, Devous MD, Sr., Rieck JR, Hebrank AC, Diaz-Arrastia R, et al. Beta-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology. 2012;78:387\u201395. https:\/\/doi.org\/10.1212\/WNL.0b013e318245d295.","journal-title":"Neurology"},{"key":"7394_CR23","doi-asserted-by":"publisher","first-page":"617173","DOI":"10.3389\/fmed.2020.617173","volume":"7","author":"Y Xie","year":"2020","unstructured":"Xie Y, Yang Q, Liu C, Zhang Q, Jiang J, Han Y, et al. Exploring the pattern associated with longitudinal changes of beta-Amyloid deposition during cognitively normal healthy aging. Front Med (Lausanne). 2020;7:617173. https:\/\/doi.org\/10.3389\/fmed.2020.617173.","journal-title":"Front Med (Lausanne)"},{"key":"7394_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","volume":"23","author":"U Rub","year":"2013","unstructured":"Rub U, Hoche F, Brunt ER, Heinsen H, Seidel K, Del Turco D, et al. Degeneration of the cerebellum in Huntington\u2019s disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. Brain Pathol. 2013;23:165\u201377. https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00629.x.","journal-title":"Brain Pathol"},{"key":"7394_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/jcbfm.2009.190","volume":"30","author":"VJ Cunningham","year":"2010","unstructured":"Cunningham VJ, Rabiner EA, Slifstein M, Laruelle M, Gunn RN. Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited. J Cereb Blood Flow Metab. 2010;30:46\u201350. https:\/\/doi.org\/10.1038\/jcbfm.2009.190.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7394_CR26","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1038\/s41598-020-62532-8","volume":"10","author":"MA Krueger","year":"2020","unstructured":"Krueger MA, Calaminus C, Schmitt J, Pichler BJ. Circadian rhythm impacts preclinical FDG-PET quantification in the brain, but not in xenograft tumors. Sci Rep. 2020;10:5587. https:\/\/doi.org\/10.1038\/s41598-020-62532-8.","journal-title":"Sci Rep"},{"key":"7394_CR27","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1177\/0271678X16673646","volume":"37","author":"C DeLorenzo","year":"2017","unstructured":"DeLorenzo C, Gallezot JD, Gardus J, Yang J, Planeta B, Nabulsi N, et al. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [(11)C]ABP688 and [(18)F]FPEB. J Cereb Blood Flow Metab. 2017;37:2716\u201327. https:\/\/doi.org\/10.1177\/0271678X16673646.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7394_CR28","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/sleep\/27.7.1245","volume":"27","author":"DJ Buysse","year":"2004","unstructured":"Buysse DJ, Nofzinger EA, Germain A, Meltzer CC, Wood A, Ombao H, et al. Regional brain glucose metabolism during morning and evening wakefulness in humans: preliminary findings. Sleep. 2004;27:1245\u201354. https:\/\/doi.org\/10.1093\/sleep\/27.7.1245.","journal-title":"Sleep"},{"key":"7394_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s0092-8674(00)80514-0","volume":"90","author":"E Scherzinger","year":"1997","unstructured":"Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell. 1997;90:549\u201358. https:\/\/doi.org\/10.1016\/s0092-8674(00)80514-0.","journal-title":"Cell"},{"key":"7394_CR30","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","volume":"96","author":"E Scherzinger","year":"1999","unstructured":"Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, et al. Self-assembly of polyglutamine-containing Huntingtin fragments into amyloid-like fibrils: implications for Huntington\u2019s disease pathology. Proc Natl Acad Sci U S A. 1999;96:4604\u20139. https:\/\/doi.org\/10.1073\/pnas.96.8.4604.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7394_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2967\/jnumed.116.176628","volume":"58","author":"G Leurquin-Sterk","year":"2017","unstructured":"Leurquin-Sterk G, Celen S, Van Laere K, Koole M, Bormans G, Langlois X, et al. What we observe in vivo is not always what we see in vitro: development and validation of 11\u00a0C-JNJ-42491293, a novel radioligand for mGluR2. J Nucl Med. 2017;58:110\u20136. https:\/\/doi.org\/10.2967\/jnumed.116.176628.","journal-title":"J Nucl Med"},{"key":"7394_CR32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2967\/jnumed.119.236224","volume":"61","author":"A Mueller","year":"2020","unstructured":"Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, et al. Tau PET imaging with (18)F-PI-2620 in patients with alzheimer disease and healthy controls: a first-in-humans study. J Nucl Med. 2020;61:911\u20139. https:\/\/doi.org\/10.2967\/jnumed.119.236224.","journal-title":"J Nucl Med"},{"key":"7394_CR33","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1007\/s00259-021-05212-7","volume":"48","author":"Z Li","year":"2021","unstructured":"Li Z, Kong Z, Chen J, Li J, Li N, Yang Z, et al. (18)F-Boramino acid PET\/CT in healthy volunteers and glioma patients. Eur J Nucl Med Mol Imaging. 2021;48:3113\u201321. https:\/\/doi.org\/10.1007\/s00259-021-05212-7.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07394-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:31:24Z","timestamp":1762327884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07394-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":33,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["7394"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07394-w","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with World Medical Association Declaration of Helsinki and approved by the Ethics Committee Research UZ\/KU Leuven (S61676).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"AD, MK, KS, GB, KVL and WV declare that they have no competing interests. MS, VK, LL, JB, RD, JW, SS, CS and AW are employed by CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation, Inc., and declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}